SEC Seeks Quick Notes on Company Voting Conflicts
Published Date: 1/12/2026
Notice
Summary
The Securities and Exchange Commission wants to keep collecting a simple yearly notice from a few companies about their ownership and conflicts of interest during certain voting events. This notice takes just 15 minutes to file, with no extra costs involved. They’re asking for public feedback before extending this rule to make sure it’s still useful and easy to handle.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12163, The Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
The SEC wants to scrap some old rules that stop stocks from being traded at worse prices and prevent confusing market quotes. This change affects stock traders and exchanges, aiming to simplify trading and possibly speed things up. If you want to share your thoughts, you’ve got until August 17, 2026, so don’t miss out!
2026-10373, Registered Offering Reform
The SEC wants to make it easier and cheaper for more companies to sell their stocks and bonds to the public. They’re opening up special forms and benefits to more businesses, updating rules to be more modern, and cutting red tape by overriding some state rules. If you’re a company planning to raise money, these changes could speed things up and save you money, with feedback due by July 27, 2026.
2026-10222, Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
The SEC is making it easier for companies that report their finances by simplifying their categories into just two groups: big and small filers. Smaller companies, including emerging growth ones, will get more time to file reports and enjoy simpler rules, while big companies keep stricter standards. These changes aim to save time and money, with feedback open until July 20, 2026.
2026-07651, Concept Release on Consolidated Audit Trail and Other Audit Trails and Data Sources
The SEC wants your thoughts on how it tracks stock market trades using the Consolidated Audit Trail and other data tools. They’re thinking about updating rules to keep up with new tech, privacy, and security needs, and to make sure the system is fair and cost-effective. If you’re involved in the stock market or data tracking, speak up by June 22, 2026!
2026-16101, Self-Regulatory Organizations; NYSE American LLC; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Modify the NYSE American Options Fee Schedule To Amend the Manual Billable Rebate Program and Add a Credit Under the Firm Monthly Fee Cap
Starting August 3, 2026, NYSE American is updating its options fee schedule to rename and tweak the Manual Billable Program, swapping some rebates for a new bonus. They’re also adding a credit for Floor Brokers under the Firm Monthly Fee Cap, which could save some firms money. These changes mainly affect traders and firms using the Exchange’s options services.
2026-16086, Agency Information Collection Activities; Submission for OMB Review; Comment Request; Extension: Rule 15g-2
Previous / Next Documents
Previous: 2026-00323, Arms Sales Notification
The U.S. is planning to sell $120 million worth of training helicopters and support gear to the Philippines, helping boost their military skills without any major weapons involved. This deal includes helicopters, simulators, spare parts, and training services, all funded by foreign military financing. The Navy is handling the sale, which aims to strengthen ties and improve readiness soon.
Next: 2026-00325, Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products; Draft Guidance for Industry; Availability
The FDA just dropped a draft guide to help drug makers use Bayesian methods in clinical trials, making it easier to prove a drug’s safety and effectiveness. This affects companies testing new drugs and biologics, offering a fresh, smarter way to analyze trial results. Comments are open until March 13, 2026, so get your thoughts in early to shape the final rules—this could speed up approvals and save money down the road!